Prefilled Syringes Market Size, Patient Adoption Rates, Product Utilization, Pricing Analysis, Regulatory Landscape, Market Share, and Demand Forecast

Revenue, 2025

USD 21.59 Bn

Forecast Year, 2035

USD 64.69 Bn

CAGR, 2026 - 2035

11.60%

Report Coverage

Global

What is Prefilled Syringes Market Size?

The prefilled syringes market size accounted for USD 21.59 billion in 2025, and is anticipated to hit around USD 24.13 billion by 2026, and is expected to reach around USD 64.69 billion by 2035, expanding at a CAGR of 11.60% from 2026 to 2035. Prefilled syringes are in high demand because they eliminate overfilling of expensive drug products, reduce waste, and avoid dosage errors.

Market Highlights

• Europe led the global market with the highest market share of 40% in 2025.
• By Type, the safety prefilled syringes segment captured the biggest revenue share in 2025.
• By Material, the glass prefilled syringes segment is estimated to hold the highest market share in 2025.
• By Design, the single-chamber prefilled syringes segment has held the largest market share in 2025.

Market Overview

What are Prefilled Syringes?

Prefilled syringes provide ease of administration due to minimum steps and add convenience for healthcare workers and end users. They can be used during emergencies and enable easier self-administration. They also help to reduce medical errors and misidentification. They have lower costs due to fewer materials, less preparation, and easy storage and disposal. The prefilled syringes market is expanding due to the potential features of these syringe systems to mitigate the risk associated with drug delivery through vial containment systems.

How has AI benefited the Prefilled Syringes Industry?

Artificial intelligence has remarkably benefited the prefilled syringes industry by improving manufacturing precision, enhancing quality control via advanced inspection, and driving the development of "smart" drug delivery systems. AI allows predictive maintenance, anticipating equipment failures to decrease downtime. It also optimizes the production line by accepting acceptable variations in materials, thus minimizing false rejections.

Prefilled Syringes Market Growth Factors

• A pre-filled syringe is also recognized as a package which is comprised of single-dose of medicine in which an attached needle also provided by the manufacturer. Previously, metal or glass syringes were very common in the industry of industry, but slowly & steadily consumer shift have been observed more towards disposable or plastic syringes in order to secure the needle and make it use and throw so that it cannot be re-utilized. In addition, this has revitalized the demand towards safe and convenient pre-filled syringes in the pharmaceutical market over conventional glass vials for storing drugs.
• The impact of the driving factors is anticipated to surpass the effect of restraints. Also, the technological advancements leading to advanced adoption rate and untapped markets in the developing countries are anticipated to give new avenues for the growth of market in the near future. Likewise, growing use of technological advancements and prefilled syringes in auto-injectors are the crucial factors propelling the market. Furthermore, prefilled syringes are fleetly swapping traditional combinations of syringe-vial owing to advantages provided by them, similar as convenience for healthcare practitioners and increased patient safety in cure medication and delivery.
• These syringes enable easy operation of chronic diseases, similar as rheumatoid arthritis, and diabetes which is anticipated to boost the use of auto-injectors and pen injectors during the forecast period. Therefore, the growing frequency of chronic disease like diabetes and other diseases is likely to fuel the market demand over the upcoming time period. In addition, the launch of advanced equipment with Wi-Fi and Bluetooth connectivity easing effective operation of patient health records is also anticipated to boost the product demand.
• In addition, the usage of pre-filled syringe has skyrocketed owing to the numerous difficulties in the traditional process. There are various advantages pre-filled syringes have in place of traditional packaging in vials which comprise of ease in use. As prefilled syringes efficiently mitigate the processes which is further required before using any drug in a vial. Moreover, it further helps in removing errors while providing doses to the patient's as prefilled syringes are importantly comprise of the exact dose required for the patient. In addition, numerous producers of pharmaceuticals overfill their vials by up to 18%, however, this overfilled of vials is likely to cause many errors while giving a dose to the patient which can easily be mitigated with the help of the pre-filled syringes. Also, there exists excessive syringes development and various new products have been launched and are being kept in syringes now for the microbial safety. Pre-filled syringes are used in the packaging of injectable and diluents drugs. Some of the majorly listed drugs packaged in pre-filled syringes includes vaccines, blood stimulants, ervthroproteins, therapeutic proteins, and rheumatoid arthritis. Thus, comfort in utilization and better safety of the drug is the major factor which is leading to rise in demand for prefilled syringes in the market.
• The demand for prefilled syringes has risen due to the COVID-19 pandemic. The surge in number of COVID-19 patients is paving new ways for the growth of the global prefilled syringes market during 2020. Another factor boosting the growth of the global prefilled syringes market is growing incidences of rheumatoid arthritis and diabetes all over the world. In addition, the growing concerns about the safety of injectables are propelling the prefilled syringes market. The growing technological developments in the prefilled syringes market are also driving the demand for prefilled syringes. The prefilled syringes are widely adopted in the developed and developing regions such as North America and Europe. Moreover, the surge in demand for biosimilars is also contributing to the growth of the prefilled syringes market.

Prefilled Syringes Market Trends

• The Rise of Prefilled Syringes in Drug Delivery: There has been immense progress in manufacturing, transportation, drug preservation, and storage, including cold chain and advanced technologies. With the developments in biologics, pharmaceuticals, drug delivery, and biosimilars, there is a rising trend of self-administering injectable medication in a home setting. It has encouraged manufacturers to reconsider the vial-ampule-syringe format.
• Viability of Modern Prefilled Syringes: They are made up of both glass and exotic plastics, and are available in different sizes and designs, with the 1.0 mL syringe being the most popular. Glass remains the ideal material of choice due to its flexibility, manufacturing ability, sterilization process, weight, ease of use, strength, dimensional stability, and inertness. It is transparent and can be colored, and allows visual inspection of a fill before injection and during manufacturing.
• Safety Innovations: There are growing concerns about needle-stick injuries, and numerous prefilled devices offer retractable needles or automatic needle shielding. Multiple companies are making efforts to resolve issues related to needle safety and the disposal of prefilled syringes. Innovative designs for safety needles and prefilled syringes are coming to the market.

Prefilled Syringes Market Outlook

• Market Growth Overview: The prefilled syringes market is expected to grow significantly between 2026 and 2035, driven by the rising burden of chronic diseases, the shift towards self-administration, and the expansion of biologics and biosimilars.
• Sustainability Trends: Sustainability trends involve a shift towards eco-friendly materials, packaging optimization and waste reduction, and take-back and recycling programs.
• Major Investors: Major investors in the market include Becton, Dickinson and Company (BD), Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Stevanato Group, and Novartis AG.
• Startup Economy: The startup economy is focused on novel materials and manufacturing, smart syringes and connectivity, and patient-centric delivery and usability.

Market Scope

Market Dynamics

Driver

How do Innovations meet Growing Demand for Prefilled Syringes?

The prefilled syringes market is growing and expanding due to the potential of these syringes to boost productivity and output, enhance operations, and support increased automation of the fill or finish line. Syringe innovations also increase the safety and efficiency of patients and caregivers. They also reduce waste of product and packaging materials. They minimize the risk of injection errors, non-sterility issues, and dilution errors.

Restraint

What are the Potential Challenges Facing Manufacturers in the Prefilled Syringes Market?

Manufacturers of prefilled syringes face challenges in ensuring long-term compatibility between biologics and syringe materials, and predicting the impact of patient behavior on syringe usage over time. Moreover, there are growing concerns around sustainability in pre-filled syringe production. They also focus on mitigating risks associated with syringe variability during mass production.

Opportunity

What are the Fruitful Doors for the Growth of the Prefilled Syringes Market?

Prefilled syringes are an easy-to-use option for millions of at-home patients. Self-administration allows the patient to take the exact dosage at the time of emergency. The pharmaceutical industry is dedicated to introducing safe and effective therapies to patients in need. Healthcare providers and patients look for more convenient methods to obtain the positive outcomes from medications.

Segments Insights

Type Insights

Why did the Safety Prefilled Syringes Segment Dominate the Prefilled Syringes Market?

The safety prefilled syringes segment led the market in 2025. This is due to the critical demand to reduce needle-stick injuries and even prevent the transmission of blood-borne diseases such as HIV and Hepatitis. Governments in many regions have implemented laws demanding the use of safety-engineered devices to protect against injuries. These syringes improve convenience, provide accurate dosing, and decrease the need for and risks linked with manual drug preparation.

The conventional prefilled syringes segment is expected to grow at the fastest CAGR throughout the forecast period. This is due to its high cost-effectiveness, widespread acceptance in hospitals and clinics, and proven reliability. These syringes provide superior convenience by eliminating medication preparation, enhancing dosing accuracy, reducing contamination risks, and improving patient compliance, mainly for chronic condition treatments. They are ready-to-use, which decreases the time required for preparation, reduces medication errors, and even lowers the risk of needle stick injuries.

On the basis of type, safety prefilled syringes segment is likely to foresee the loftiest growth during the forthcoming time period majorly owing to the growing senior population worldwide and biological therapies availabilities for patients with suffering from chronic diseases and low- threat medical procedures outsourcing for chronic patients ease some of the pressure on hospitals.

Material Insights

Why did the Glass Segment Dominate the Prefilled Syringes Market?

The glass segment dominated the market in 2025. The market is primarily because of its superior inertness, which guarantees drug stability and prevents interactions with sensitive biologics, along with high-viscosity drugs. Glass is highly inert, meaning it has low reactivity with medications, which thus prevents leaching and contamination. Glass syringes have a long history of compliance, thus making them the standard option for regulatory approval.

The plastic segment is expected to grow at a significant CAGR in the upcoming period, because of its lightweight, break-resistant, and cost-effective nature. It is ideal for high-volume vaccine production along with self-administration. Plastic enables easier integration with safety mechanisms, like needle shields and retractable needles.

The glass prefilled syringes segment reckoned for the largest share of the prefilled syringes in 2025. The large share of this segment is attributed to the significant benefits offered, similar as forestallment of oxygen and water vapor from interacting with medicine composites, comity with different stuffing machines, and flawless integration into pharmaceutical companies PFS operations.

Design Insights

Why did the Single-Chamber Segment Dominate the Prefilled Syringes Market?

The single-chamber segment dominated the market in 2025. The market is primarily because of its simplicity, cost-effectiveness, and widespread usage for chronic diseases, vaccines, and biologics. Single-chamber designs are generally cheaper to produce in large volumes compared to complex dual-chamber systems. These syringes decrease medication preparation time, reduce contamination risks, and enable accurate, quick administration, making them ideal for emergency care and even high-volume vaccinations.

The dual-chamber segment is expected to grow at a significant CAGR in the upcoming period, because of the need for improved stability of biologics, lyophilized drugs, and vaccines, which demand mixing immediately before administration. They provide improved patient safety, reduced contamination risk, along with better convenience for self-administration of chronic diseases, for example, rheumatoid arthritis, hemophilia, compared to traditional vials.

The single chamber prefilled syringes segment reckoned for the largest share of the prefilled syringes market. Furthermore, the market growth is majorly attributed to the significant benefits with the usage of prefilled syringes of single-chamber over vials, similar as optimized API use with lower overfill, lower medicine waste in clinical trials, reduced material requirements, and simple storage& disposal. Also, upsurge in self-administered parenteral medicines adoption owing to the adding frequency of various chronic diseases and advantages offered by them.

Product Insights

How does the Complete Syringe Set Segment Dominate the Prefilled Syringes Market in 2025?

The complete syringe set segment dominated the market in 2025, owing to its key role in ensuring patient safety, drug stability, and minimizing expensive manufacturing waste. It is essential because it provides major benefits such as leak prevention, contamination barrier, and shelf-life extension. It also enhances patient safety and compliance through accurate dosing, needlestick protection, and ease of use.

The components and accessories segment is expected to grow at the fastest CAGR in the market during the forecast period due to the emerging need to consider the potential interactions with direct contact materials and primary packaging components. There is a growing focus on understanding the importance of pre-filled drug containers and pre-filled syringes, which are used in combination with drug delivery devices. The primary packaging components and materials have a great impact on drug quality, efficacy, and safety. Also, there is a great influence of extractables and leachables, sub-visible particles, handling, manipulation, and silicone oil, etc.

Application Insights

What made Diabetes the Dominant Segment in the Prefilled Syringes Market in 2025?

The diabetes segment dominated the market in 2025, owing to reduced injection anxiety from preloaded configurations that feature finer, smaller needles. They result in a less painful and more comfortable injection process. Many prefilled insulin delivery pens enable patients with low vision or diabetic retinopathy to measure doses safely by sound, and these pens feature audible click selectors.

The cancer segment is estimated to grow at the fastest rate in the market during the predicted timeframe due to the pivotal role of prefilled syringes in protecting immunocompromised patients, eliminating high-stakes dosing errors, and safer handling of harmful oncology drugs. Monoclonal antibodies, highly complex biological therapies, and supportive care drugs become central to cancer treatment. The use of prefilled syringes in cancer care is beneficial in terms of harmful material management, patient protection, and clinical efficiency.

Closing System Insights

How did the Staked Needle System Segment Dominate the Prefilled Syringes Market in 2025?

The staked needle system segment dominated the market in 2025, owing to the benefits associated with staked prefilled syringes such as safety, sterility, convenience, reduced waste, and patient comfort. Staked needle syringes possess a ready-to-use design that simplifies the injection process to save time for healthcare professionals. They are ideal for quick and efficient administration of medications, particularly in emergency settings.

The luer lock form system segment is anticipated to grow at the fastest rate in the market during the upcoming period due to a secure connection between the needle or a device and a syringe. It prevents accidental disconnection and avoids several medical complications. The Luer lock syringe is ideally designed to provide more accurate and precise delivery of medication.

End User Insights

Why did the Pharmaceutical and Biotechnology Companies Segment Dominate the Prefilled Syringes Market in 2025?

The pharmaceutical and biotechnology companies segment dominated the market in 2025, owing to the numerous process and sterility advantages of ready-to-use containers for many pharmaceutical manufacturers. The ready-to-use containers have provided scalable and feasible solutions for many new and evolving parenteral products. The prefilled syringes are boosting manufacturing yields, securing market share, and extending drug product lifecycles through enhanced patient safety.

The contract research and manufacturing organizations segment is predicted to grow at a rapid rate in the market during the studied period due to their central role in filling the gap between efficient commercial production and complex drug development. The heavy reliance of GLP-1 weight loss drugs, biosimilars, and biologics on prefilled syringe delivery systems increases the revenue growth of CRMOs. The premium offerings have shifted capabilities from conventional vials to pre-filled syringes, which allows CRMOs to charge higher margins.

Regional Insights

Europe Prefilled Syringes Market Size and Growth 2026 to 2035

The Europe prefilled syringes market size is estimated at USD 8.64 billion in 2025 and is predicted to be worth around USD 25.87 billion by 2035, at a CAGR of 11.59% from 2026 to 2035.

Europe: Germany Prefilled Syringes Market Trends

Germany's market growth is driven by the aging population and high prevalence of chronic diseases. The push for self-administration of medicines and a strong regulatory environment favouring safe, user-friendly solutions. Technological innovations, such as smart and safety-featured syringes, are becoming commonplace, with glass counting to be the dominant material choice for high-value biologic drugs.

Europe is one of the major profit-generating regions in the prefilled syringes market. Rising frequency of chronic conditions, technological advancements, growth of the biologics and biosimilars market, geographical expansion by crucial manufacturers, growing population, and high adoption of tone-injection bias are driving the demand for tone-injectable prefilled syringes are the major factors driving the growth of the prefilled syringes market in Europe.

Due to expanding access to healthcare, increased uptake of advanced drug delivery systems, and increased awareness of patient safety, Asia Pacific is quickly becoming a growth hub for the prefilled syringe market. Furthermore, with Asia Pacific being one of the largest population bases in the world, bettering regulatory frameworks, local pharmaceutical manufacturing, and growing investments from global players, this puts the growth of the Asia Pacific region even more in focus as a key component of this market expansion.

How Did North America Dominate the Prefilled Syringes Market?

North America's market growth is driven by the high prevalence of chronic diseases, such as diabetes and autoimmune disorders, which necessitate frequent injections. The region benefits from a highly advanced healthcare infrastructure and substantial expenditure that accelerates the adoption of new medical technologies. Stringent U.S. FDA safety regulations heavily promote the use of pre-measured, safety-engineered syringes to minimize medication errors and needlestick injuries.

U.S. Prefilled Syringes Market Trends

The U.S. market is a growing sector driven by the high prevalence of chronic diseases and a strong regulatory emphasis on patient safety. A significant trend toward patient self-administration and home healthcare is fueling the demand for convenient, ready-to-use syringes.

Advancements of Latin America to Stimulate the Prefilled Syringes Sector

Latin America's advancement in the prefilled syringes accelerated when the sector transformed its traditional ground into patient-supportive self-service systems, particularly for rheumatoid arthritis and diabetes. Regional partnerships to fuel tech integration and manufacturing extension are a major advancement for prefilled syringes. Brazil's heavy investment is a valuable contribution to the region's advancement and growth.

Whereas, Colombia and Argentina are new facilities that strongly aims on pharmaceutical outsourcing and infrastructure establishment. With the power of millions of profits, Latin America has a sufficient amount of financial strength to further boost its advanced performance in prefilled syringes.

Brazil Prefilled Syringes Market Trends

Brazil's major trends lie in the biopharmaceuticals expansion rate, as biosimilars and new promising biologic medications are one of the fundamental drugs qualifying on the basis of precision dosing. The dosing is served by prefilled syringes to confirm safety and efficacy. The home healthcare trend promotes self-administration solutions.

The demand for convenience for indoor patients is rising with the geriatric or busy population, due to which the ready-to-use delivery method is accelerating. Alongside, intelligent packaging is gaining necessary popularity to detect expiry dates and track the usage appropriately.

Asia-Pacific Initiatives in the Prefilled Syringes Industry

Asia-Pacific government initiatives are a major contributor to the prefilled syringes market globally, as they also play a role in raising awareness and addressing new regulatory fluctuations, supporting or transitioning the sector overall. India and China deliver export subsidies, low-interest loans, and tax rebates that empower local manufacturers of the excessively produced medical devices, involving auto-disable and prefilled syringes.

The government-sponsored vaccination campaigns in the massive population region promote dosing accuracy and quick access (delivery). The Central Drugs Standard Control Organisation (CDSCO) guidelines, mainly for drug-device merger elevates approval of products in the biologics setting and confirm safety.

China's Prefilled Syringes Market Trends

China's trend revolves around the crucial biologics demand for smart drug delivery systems, mainly for anticoagulants, monoclonal antibodies, and insulin, due to which the demand for glass barrels instantly rises. The region is leading with the increased regulatory approvals and its key focus on local production.

Following this, the innovative and effective products get equal position as the market rises. The rising prevalence of chronic disease has stimulated and provoked the growth of the home care system regarding prefilled syringes, featuring convenience and comfort for the patient population. Local pharmaceutical companies plays important role in the growth of China's trend growth.

Rising Demand for Prefilled Syringes in MEA

MEA shows a rapid growth during the forecast period. It is driven by the high prevalence of chronic diseases such as diabetes and cancer, demanding consistent self-administration. The rising use of advanced, sensitive biologic therapies, which require precise dosage and, in many cases, self-injection, is boosting the acceptance of prefilled syringes.

Increased government spending on healthcare, mainly in the UAE and Saudi Arabia, has led to enhanced healthcare access and a drive toward adopting modern medical devices.

What is the Major Footprint of Saudi Arabia in the Prefilled Syringes Market?

Saudi Arabia is transforming due to government healthcare reforms, expansion of local manufacturing and assembly, patient preference for self-administration, and national immunization drives. The government interventions under Vision 2030 aimed at localizing pharmaceutical supply chains, healthcare modernization, and mandating advanced clinical safety measures.

Value Chain Analysis of the Prefilled Syringes Market

• Raw Material & Component Manufacturing
  This initial stage focuses on the production of the syringe barrel (typically glass or polymer), the plunger stopper, needle shield, and other critical components.
  Key Players: Gerresheimer AG, SCHOTT AG, and West Pharmaceutical Services, Inc.
• Prefilled Syringe Filling and Finishing (Drug Manufacturing)
  This stage involves the aseptic filling of the syringe with the drug product, followed by the insertion of the plunger stopper and needle shield.
  Key Players: Baxter International Inc. and Pfizer Inc., Vetter Pharma Fertigung GmbH, WuXi Biologics, and Ajinomoto Bio-Pharma Services.
• Distribution and Logistics
  After filling, the finished prefilled syringes are packaged, labeled, and distributed through established pharmaceutical supply chains to healthcare providers, pharmacies, and patients.
  Key Players: Cardinal Health, Inc., BD (Becton, Dickinson and Company), and Fresenius Kabi AG
• End-User Administration
  This final stage encompasses the use of the prefilled syringe by healthcare professionals in hospitals and clinics or for self-administration by patients at home. Key Players: hospitals, ambulatory surgery centers, and individual patients.

Competitive Landscape

The prefilled syringes market is dominated by primary hardware and component manufacturers like Becton, Dickinson and Company (BD), Gerresheimer AG, SCHOTT Pharma AG & Co. KGaA, West Pharmaceutical Services, Inc., Stevanato Group, Nipro Corporation, Vetter Pharma International GmbH, Terumo Corporation, Catalent, Inc., and Baxter International Inc. The industry is driven by self-administration trends, the rise of biologics, and demands for vaccine packaging. The core product offerings of these top companies are high-end glass prefillable syringes, a flagship line of glass prefilled syringes, GLP-1 prefilled syringe delivery, specialized syringe systems free of silicone oil and PFAS, and many more. The R&D focus areas are biologics compatibility, safety-engineered systems, and digital integration.

Top Companies in the Prefilled Syringes Market & Their Offerings

• SCHOTT AG: SCHOTT AG is a global leader in specialty glass and advanced materials, contributing significantly by manufacturing high-quality glass barrels and components for prefilled syringes.
• West Pharmaceutical Services, Inc.: West is a crucial component manufacturer, specializing in the stoppers, plungers, and sealing solutions that make up the container closure system for prefilled syringes.
• Baxter International Inc.: Baxter operates as both a drug manufacturer and a major user of prefilled syringe technology, contributing by utilizing these systems for a range of their own medications and providing outsourced filling services to other pharma companies.
• Weigao Group: As a major Chinese medical device manufacturer, Weigao contributes to the global and Asia-Pacific markets by producing a wide array of medical consumables, including disposable prefilled syringes and related delivery systems.
• Vetter Pharma International GmbH: Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the high-quality aseptic filling and finishing of prefilled syringes for the global biotech and pharmaceutical industries.
• Nipro Corporation: Nipro contributes through the manufacturing of glass tubing and integrated medical device components, providing essential raw materials and finished products like prefilled syringes to the global market.
• Elcam Medical: Elcam specializes in the development and manufacturing of single-use medical devices, including components and safety features for prefilled syringes.
• Oval Medical Technologies: (Acquired by Unilife) Oval focused on developing innovative, small, and patient-friendly auto-injectors and prefilled syringe systems designed for easy self-administration. Their contribution was in pushing ergonomic design and user-centric solutions to improve patient compliance with injectable therapies.
• SHL Medical AG: SHL is a world-leading designer and manufacturer of advanced drug delivery systems, particularly auto-injectors that use prefilled syringes as the primary container. They enable pharmaceutical companies to bring user-friendly, high-tech delivery solutions to market for complex biologic treatments.
• Terumo: Terumo is a global medical device company that contributes significantly to the market by manufacturing high-quality glass and polymer prefilled syringes, along with advanced safety needles.

Recent Developments

• In January 2026, West Pharmaceutical Services launched prefillable syringe systems, which are innovative solutions for injectable drug administration. The company has introduced the West Synchrony Prefillable Syringe (PFS) System at CPHI Worldwide in Germany. (Source: https://pharmaceuticalmanufacturer.media)
• In August 2025, Accord BioPharma, Inc. commercially launched IMULDOSA, a biosimilar to STELARA in the U.S. IMULDOSA is supplied as single-dose prefilled syringes for subcutaneous use or as a single-dose vial for intravenous infusion. It was approved for the treatment of adults with psoriatic arthritis, plaque psoriasis, or Crohn's disease. It was also approved for the treatment of psoriatic arthritis or pediatric plaque psoriasis for patients six years and older. (Source: https://www.goodwinlaw.com)
• In January 2025, SCHOTT Pharma, a provider of drug containment and delivery solutions, launched the next generation of SCHOTT TOPPAC infuse polymer syringes, a system designed to improve safety and efficiency. The next generation of SCHOTT TOPPAC infuse syringes can be filled on existing filling lines without requiring modifications or additional investment. (Source: https://www.contractpharma.com)
• In May 2025, Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose prefilled syringes. Zydus' generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone 20 mg/ml, 40 mg/ml and indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. (Source: https://www.businesswire.com)
• In April 2025, Argenx announced FDA Approval of VYVGART Hytrulo Prefilled Syringe for self-injection in generalized Myasthenia Gravis and chronic inflammatory demyelinating polyneuropathy. VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe. (Source: https://www.globenewswire.com)

Segments Covered in the Report

By Type

• Conventional Prefilled Syringes
• Disposable Prefilled Syringes
• Reusable Prefilled Syringes
• Safety Prefilled Syringes

By Material

• Glass
• Plastic

By Design

• Single-Chamber
• Dual- Chamber
• Customized

By Product

• Complete Syringe Set
• Components and Accessories

By Application

• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer
• Thrombosis
• Ophthalmology
• Others

By Closing System

• Staked Needle System
• Luer Cone System
• Luer Lock Form System

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research and Manufacturing Organizations
• Others

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa